Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms
- 18 June 2020
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 41 (6) , 1195-1201
Abstract
Glioma is known as one of the most common primary intracranial tumors accounting for four-fifths of malignant brain tumors. There are several biological pathways that play a synergistic, pathophysiological role in glioma, including apoptosis, autophagy, oxidative stress, and cell cycle arrest. According to previous rese arches, the drugs used in the treatment of glioma have been associated with significant limitations. Therefore, improved and/or new therapeutic platforms are required. In this regard, multiple flavonoids and alkaloids have been extensively studied in the treatment of glioma. Berberine is a protoberberine alkaloid with wide range of pharmacological activities, applicable to various pathological conditions. Few studies have reported beneficial roles of berberine in glioma. Berberine exerts its pharmacological functions in glioma by controlling different molecular and cellular pathways. We reviewed the existing knowledge supporting the use of berberine in the treatment of glioma and its effects on molecular and cellular mechanisms.Keywords
This publication has 80 references indexed in Scilit:
- Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomasCancer Medicine, 2013
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and SenescenceCell, 2012
- Apoptosis in cancer: from pathogenesis to treatmentJournal of Experimental & Clinical Cancer Research, 2011
- MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma CellsPLOS ONE, 2011
- Autophagy Interplay with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Resveratrol in Glioma CellsPLOS ONE, 2011
- The Beclin 1 network regulates autophagy and apoptosisCell Death & Differentiation, 2011
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxideBMC Cancer, 2008
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002